BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28279536)

  • 1. Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers.
    Rodríguez de Lope C; Reig M; Matilla A; Ferrer MT; Dueñas E; Mínguez B; F Castroagudín J; Ortiz I; Pascual S; Lledó JL; Gallego A; Arenas JI; Aracil C; Forne M; Muñoz C; Pons F; Sala M; Iñarrairaegui M; Martin-Llahi M; Andreu V; Garre C; Rendón P; Fuentes J; Crespo J; Rodríguez M; Bruix J; Varela M;
    Med Clin (Barc); 2017 Jul; 149(2):61-71. PubMed ID: 28279536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment approach of hepatocellular carcinoma in Spain. Analysis of 705 patients from 62 centers].
    Varela M; Reig M; de la Mata M; Matilla A; Bustamante J; Pascual S; Turnes J; Aracil C; Del Val A; Pascasio JM; Rodríguez M; Bruix J
    Med Clin (Barc); 2010 May; 134(13):569-76. PubMed ID: 20036398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
    Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
    World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HKLC Triages More Hepatocellular Carcinoma Patients to Curative Therapies Compared to BCLC and Is Associated with Better Survival.
    Wallace MC; Huang Y; Preen DB; Garas G; Adams LA; MacQuillan G; Tibballs J; Ferguson J; Samuelson S; Jeffrey GP
    Dig Dis Sci; 2017 Aug; 62(8):2182-2192. PubMed ID: 28547649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.
    Wong CR; Garcia RT; Trinh HN; Lam KD; Ha NB; Nguyen HA; Nguyen KK; Levitt BS; Nguyen MH
    Dig Dis Sci; 2009 Dec; 54(12):2712-21. PubMed ID: 19876735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study.
    Borzio M; Fornari F; De Sio I; Andriulli A; Terracciano F; Parisi G; Francica G; Salvagnini M; Marignani M; Salmi A; Farinati F; Carella A; Pedicino C; Dionigi E; Fanigliulo L; Cazzaniga M; Ginanni B; Sacco R;
    Future Oncol; 2013 Feb; 9(2):283-94. PubMed ID: 23414477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
    Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
    J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HepCar registry: report on a one-year registration program of hepatocellular carcinoma (HCC) in Belgium. What is daily practice in HCC?
    Van Vlierberghe H; Colle I; Henrion J; Michielsen P; Delwaide J; Reynaert H; Borbath I; Martinet JP; Sprengers D; Brenard R;
    Acta Gastroenterol Belg; 2005; 68(4):403-11. PubMed ID: 16432990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Percutaneous ablation of hepatocellular carcinoma in older patients in clinical practice].
    Romero Gutiérrez M; Ruano Díaz L; Muñoz López D; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; de la Cruz Pérez G; Gómez Rodríguez R
    Gastroenterol Hepatol; 2015 Feb; 38(2):54-61. PubMed ID: 25499846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatocellular carcinoma in Navarre: study of characteristics and evolution in clinical practice].
    Elizalde Apestegui IR; Saldaña Dueñas C; Goñi Esarte S; Prieto Martínez C; Sangro Gómez-Acebo B; Zozaya Urmeneta JM
    An Sist Sanit Navar; 2016; 39(2):249-60. PubMed ID: 27599952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
    Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trend of improving prognosis of hepatocellular carcinoma in clinical practice: an Italian in-field experience.
    Borzio M; Dionigi E; Rossini A; Toldi A; Francica G; Fornari F; Salmi A; Farinati F; Vicari S; Marignani M; Terracciano F; Ginanni B; Sacco R
    Dig Dis Sci; 2015 May; 60(5):1465-73. PubMed ID: 25399329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
    Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G
    World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study.
    Costentin CE; Mourad A; Lahmek P; Causse X; Pariente A; Hagège H; Dobrin AS; Becker C; Marks B; Bader R; Condat B; Héluwaert F; Seitz JF; Lesgourgues B; Denis J; Deuffic-Burban S; Rosa I; Decaens T;
    Cancer; 2018 May; 124(9):1964-1972. PubMed ID: 29589878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics, staging and treatment of patients with hepatocellular carcinoma in clinical practice. Prospective study of 136 patients].
    Gómez Rodríguez R; Romero Gutiérrez M; González de Frutos C; de Artaza Varasa T; de la Cruz Perez G; Ciampi Dopazo JJ; Lanciego Pérez C; Gómez Moreno AZ
    Gastroenterol Hepatol; 2011 Oct; 34(8):524-31. PubMed ID: 21940068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical report of 1,078 cases of hepatocellular carcinomas: National Cancer Center experience].
    Cheon JH; Park JW; Park KW; Kim YI; Kim SH; Lee WJ; Park HS; Park SJ; Hong EK; Kim CM
    Korean J Hepatol; 2004 Dec; 10(4):288-97. PubMed ID: 15613804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study.
    Kim BK; Kim DY; Han KH; Seong J
    PLoS One; 2019; 14(10):e0223678. PubMed ID: 31622424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiological, clinical and therapeutic features of hepatocellular carcinoma in cirrhotic patients].
    Said Y; Debbeche R; Ben Ali Z; Bouzid K; Trabelsi S; Bouzaidi S; Salem M; Rajhi H; Kouni Chahed M; Najjar T
    Tunis Med; 2012 Jun; 90(6):468-72. PubMed ID: 22693088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
    Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
    J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening for hepatocarcinoma in a cohort with cirrhosis mainly of alcoholic origin].
    Henrion J; Libon E; De Maeght S; Deltenre P; Schapira M; Ghilain JM; Maisin JM; Heller FR
    Gastroenterol Clin Biol; 2003 May; 27(5):534-9. PubMed ID: 12843918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.